Wilms Tumor - 28/06/23
Doi : 10.1016/j.ucl.2023.04.008
Amanda F. Saltzman, MD a, Nicholas G. Cost, MD b, c, ⁎ 
, Rodrigo L.P. Romao, MD d, e
, Rodrigo L.P. Romao, MD d, e a Department of Urology, University of Kentucky, Lexington, KY, USA
b Division of Urology, Department of Surgery, University of Colorado School of Medicine, 13123 East 16th Avenue, B 463, Aurora, CO 80045, USA
c Surgical Oncology Program, Children’s Hospital Colorado, 13123 East 16th Avenue, B 463, Aurora, CO 80045, USA
d Department of Surgery, IWK Health Centre, Dalhousie University, Halifax, Canada
e Department of Urology, IWK Health Centre, Dalhousie University, Halifax, Canada
∗Corresponding author.
Résumé |
Wilms tumor (WT), or nephroblastoma, is the most common primary malignant renal tumor of childhood. It is an embryonal tumor that develops from remnants of immature kidney. There are approximately 500 new WT cases diagnosed in the United States every year. Advances in multimodal therapy including surgery, chemotherapy, and radiation therapy given according to risk stratification have allowed most patients to achieve survival rates in excess of 90%.
Le texte complet de cet article est disponible en PDF.Keywords : Wilms tumor, Nephroblastoma, Renal tumor, Nephrectomy, Urologic oncology
Plan
© 2023
Elsevier Inc. Tous droits réservés.
Vol 50 - N° 3
P. 455-464 - août 2023 Retour au numéro
Article précédent
- What Adults Teach Urologists About Hypospadias
- Warren Snodgrass, Nicol Bush
- Pediatric Stone Disease : Current Trends and Future Directions
- Ching Man Carmen Tong, Jonathan S. Ellison, Gregory E. Tasian
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?